Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Anika Therapeutics (ANIK) Shares Repurchased (2024 - 2025)

Anika Therapeutics (ANIK) has disclosed Shares Repurchased for 3 consecutive years, with $5.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Repurchased fell 1.09% to $5.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.5 million, a 13.09% decrease, with the full-year FY2025 number at $9.5 million, down 13.09% from a year prior.
  • Shares Repurchased was $5.5 million for Q4 2025 at Anika Therapeutics, up from $4.0 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $5.6 million in Q4 2024 to a low of $1.4 million in Q2 2024.